ALAMEDA, Calif.–BioTime, Inc. (NYSE Amex: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced the successful completion of ISO 10993 biocompatibility studies for HyStem®-Rx. These tests, as prescribed by the International Organization for Standardization for permanent implantable medical devices, are required by the United States Food and […]
Meridian Bioscience Receives FDA Clearance for New Molecular Test: illumigene® Group B Streptococcus
CINCINNATI, Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that it has received FDA clearance for a new molecular diagnostic test for Group B Streptococcus (GBS) on the illumigene® platform. This innovative test is a strong addition to the illumigene platform. Group B Streptococcus, or GBS, continues to be a major perinatal pathogen, for […]
SEATTLE & SAN ANTONIO, Texas, NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced positive results from the first clinical validation study of its first in vitro diagnostic product, a breast cancer assay based on the PAM50 gene expression signature. The study, which […]
INDIANAPOLIS, Roche announced today that it has signed an agreement under which it will acquire 100 percent of Verum Diagnostica GmbH, based in Munich, Germany. Verum Diagnostica is a leading company in platelet function testing, the fastest-growing field in the coagulation diagnostics market. The acquisition supports plans Roche announced in October to expand its coagulation […]
SANTA CLARA, Calif. Affymetrix, Inc., today announced that it has signed a definitive agreement to acquire eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. Under the terms of the agreement, Affymetrix will acquire eBioscience for $330 million in […]
Oxford, UK, Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has launched its brand new website. The new content-rich site provides authoritative insight into the latest developments, tools and issues in genomics research. Intuitive navigation makes it easy for users to find relevant resources matching their requirements, […]
Venlo, The Netherlands – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched a project to enhance productivity by streamlining the organization and freeing up resources for reallocation to strategic initiatives that will help drive growth and innovation, strengthen its industry leadership position and improve longer-term profitability. This project aims to eliminate organizational layers […]
Microfluidics expert, Dolomite, is delighted to announce its collaboration with Clearbridge BioMedics in the development of a novel instrument capable of detecting and isolating Circulating Tumour Cells (CTCs) from small quantities of whole, unprocessed blood. The innovative ClearCell™ System can isolate, enumerate and most importantly retrieve wholly intact and viable CTCs from patient whole blood. […]
INDIANAPOLIS – Roche announced today the establishment of a strategic alliance with Cedars-Sinai Medical Center in Los Angeles for the center to operate as a Roche Molecular Center of Excellence (MCOE) for the next five years. As a nationally recognized Roche MCOE, the Medical Center’s molecular diagnostics laboratory will be one of the first centers […]
LAUSANNE, Switzerland – Funds Will be Used to Commercialize a Fully Automated, Compact Molecular Diagnostics System Designed to Drive the Widespread Adoption of Personalized Medicine and Other Diagnostic Applications Including the Fight Against Infectious Disease Biocartis, a company developing and commercializing compact molecular diagnostic (MDx) systems designed to drive the widespread adoption of personalized medicine […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
